Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants

NCT01763268 is registered in ClinicalTrials.gov with Queen Sirikit National Institute of Child Health as lead sponsor.

NCT NCT01763268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01763268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
Lead sponsor
Queen Sirikit National Institute of Child Health
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 30, 2012
Completion date
August 31, 2015
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunogenicity, reactogenicity